Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Buy
10,419
+298
+3% +$41.2K 0.61% 36
2026
Q2
$1.3M Sell
10,121
-156
-2% -$18.3K 0.6% 38
2026
Q1
$1.24M Buy
10,277
+1,037
+11% +$120K 0.7% 31
2025
Q4
$973K Buy
+9,240
New +$867K 0.59% 40

Other funds holding MRK

XXI Wealth's MRK Position: Q3 2026 in Review

XXI Wealth increased its Merck (MRK) stake by 2.9% in Q3 2026, buying an estimated $41.2K and bringing the position to 10,419 shares worth $1.51M. The position accounts for 0.61% of the portfolio, ranked #36.

XXI Wealth first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,564 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • XXI Wealth held 10,419 shares of Merck worth $1.51M as of Q3 2026.
  • XXI Wealth bought 298 Merck shares in Q3 2026, an estimated $41.2K.
  • Merck made up 0.61% of XXI Wealth's portfolio in Q3 2026, its #36 holding.
  • XXI Wealth first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,564 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.